BR9503832A - Composição farmacêutica de nizatidina processo para prepação de uma forma de nizatidina e forma de nizatidina assim preparada - Google Patents

Composição farmacêutica de nizatidina processo para prepação de uma forma de nizatidina e forma de nizatidina assim preparada

Info

Publication number
BR9503832A
BR9503832A BR9503832A BR9503832A BR9503832A BR 9503832 A BR9503832 A BR 9503832A BR 9503832 A BR9503832 A BR 9503832A BR 9503832 A BR9503832 A BR 9503832A BR 9503832 A BR9503832 A BR 9503832A
Authority
BR
Brazil
Prior art keywords
nizatidine
preparing
nitro
iii
prepared
Prior art date
Application number
BR9503832A
Other languages
English (en)
Inventor
Mary Kay Mccauley
Kenneth Philip Moder
Jeffrey Lynn Speakman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9503832A publication Critical patent/BR9503832A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9503832A 1994-08-30 1995-08-29 Composição farmacêutica de nizatidina processo para prepação de uma forma de nizatidina e forma de nizatidina assim preparada BR9503832A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
BR9503832A true BR9503832A (pt) 1996-09-10

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9503832A BR9503832A (pt) 1994-08-30 1995-08-29 Composição farmacêutica de nizatidina processo para prepação de uma forma de nizatidina e forma de nizatidina assim preparada

Country Status (24)

Country Link
US (1) US5470865A (pt)
EP (1) EP0704214B1 (pt)
JP (1) JPH0892087A (pt)
KR (1) KR960006921A (pt)
CN (1) CN1127635A (pt)
AT (1) ATE192039T1 (pt)
AU (1) AU700488B2 (pt)
BR (1) BR9503832A (pt)
CA (1) CA2157240A1 (pt)
CO (1) CO4410183A1 (pt)
CZ (1) CZ189395A3 (pt)
DE (1) DE69516475T2 (pt)
ES (1) ES2145221T3 (pt)
FI (1) FI954050L (pt)
HU (1) HUT72672A (pt)
IL (1) IL115012A0 (pt)
NO (1) NO952825L (pt)
NZ (1) NZ272833A (pt)
PE (1) PE33696A1 (pt)
PH (1) PH31452A (pt)
PL (1) PL310207A1 (pt)
TR (1) TR199500885A2 (pt)
YU (1) YU57495A (pt)
ZA (1) ZA957281B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4828678B2 (ja) * 1998-11-18 2011-11-30 武田薬品工業株式会社 圧縮成形物
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
KR102178793B1 (ko) * 2019-04-17 2020-11-13 황용석 순금 장식연결구

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
HU190527B (en) * 1983-02-07 1986-09-29 Eli Lilly And Co,Us Process for preparing thiazole derivatives
EP0230127A1 (en) * 1985-12-18 1987-07-29 Eli Lilly And Company Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
ATE86619T1 (de) * 1987-04-06 1993-03-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
EP0396830B1 (en) * 1989-05-10 1993-10-27 Council of Scientific and Industrial Research An improved process for the preparation of 1-substituted amino-1-substituted thio-2-nitro alkenes
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Also Published As

Publication number Publication date
EP0704214B1 (en) 2000-04-26
IL115012A0 (en) 1996-01-31
NO952825L (no) 1996-03-01
ZA957281B (en) 1997-02-28
DE69516475D1 (de) 2000-05-31
PL310207A1 (en) 1996-03-04
ES2145221T3 (es) 2000-07-01
HUT72672A (en) 1996-05-28
PE33696A1 (es) 1996-08-29
AU3033495A (en) 1996-03-14
EP0704214A1 (en) 1996-04-03
CO4410183A1 (es) 1997-01-09
NO952825D0 (no) 1995-07-17
FI954050A7 (fi) 1996-03-02
DE69516475T2 (de) 2000-09-28
FI954050L (fi) 1996-03-02
PH31452A (en) 1998-11-03
YU57495A (sh) 1999-07-28
JPH0892087A (ja) 1996-04-09
ATE192039T1 (de) 2000-05-15
TR199500885A2 (tr) 1996-06-21
CN1127635A (zh) 1996-07-31
HU9502542D0 (en) 1995-10-30
US5470865A (en) 1995-11-28
KR960006921A (ko) 1996-03-22
NZ272833A (en) 1997-04-24
CZ189395A3 (en) 1996-03-13
AU700488B2 (en) 1999-01-07
FI954050A0 (fi) 1995-08-29
CA2157240A1 (en) 1996-03-01

Similar Documents

Publication Publication Date Title
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
DE3482982D1 (de) Herstellung von l-aminosaeuren durch transaminierung.
BR8901325A (pt) Composicao para proteger as plantas,processos para a preparacao de compostos e para a preparacao de uma composicao e processo para proteger plantas
BR9503832A (pt) Composição farmacêutica de nizatidina processo para prepação de uma forma de nizatidina e forma de nizatidina assim preparada
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
IT1137382B (it) Vaccino vivente modificato per proteggere i cani contro infezioni da parvovirus canino, metodo di produzione e uso di detto vaccino
MX9200977A (es) Proceso para producir l-lisina por fermentacion.
RU96115481A (ru) Способ лечения деформирующего остеоартроза крупных суставов
IT7829682A0 (it) Procedimento per la preparazione di acidi alfa, omega -dicarbossilici.
FR2523965B1 (fr) (benzimidazolyl-1)-1, n-((hydroxy-4 methoxy-3 phenyl)-2 hydroxy-2 ethyl) amino-3 butane et ses sels a activite b-adrenergique, leurs applications therapeutiques, et procede pour les preparer
DE69521200D1 (de) Formulierung von energie
ES502121A0 (es) Metodo para la preparacion de n-(2-(((5-dialquilamino)-me- til-2-metil-2-furanil)-metil)-etil)-n'alquil-2-nitro-1,1- etendiamina
ES515068A0 (es) "procedimiento para la preparacion de n-(2-(((5-dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-(3,4-metilendioxibencil)-2-nitro-1,1-etendiamina".
EP0342565A3 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen
BR7708543A (pt) Processo para regular o crescimento de plantas leguminosas,e composicao para aplicacao no mesmo
AT369365B (de) Verfahren zum herstellen von neuen 5-(2-((2,3dihydro-1,4-benzodioxan-2-ylmethyl)-amino)-1hydroxy[thyl)-2-hydroxybenzoes[urederivaten
BE894630A (fr) Nouveaux derives de 20, 21-dinoreburnamenine eventuellement substitues sur le cycle e, procede et intermediaires de preparation, application comme medicament et compositions les renferment
AT386200B (de) Verfahren zur herstellung von n-(2-(((5-(dimethyl-amino)-methyl-2-furanyl)met yl)thio)-aethyl)-n' -methyl-2-nitro-1,1-aethendiamin
FI972528L (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe
ATE5136T1 (de) Verfahren zur herstellung von n-(1'alkoxycarbonyl[thyl)-2,6-dialkylanilinen.
ES497386A0 (es) Procedimiento para la obtencion de la n-(2-( ( (5-( (dimeti-lamino)metil)-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1-etenodiamina
DK157494C (da) Fremgangsmaade til fremstilling af n-(2(((5-((dimethylamino)-methyl)-2-furanyl)methyl)thio)ethyl)-n'(3,4-methylendioxybenzyl)-2-nitro-1,1-ethendiamin
IT1169237B (it) Metodo per l'isolamento e la purificazione della n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina
BR9104742A (pt) Composicao aquosa,e,processo para inibir o crescimento de microorganismos

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law